Spotlight on Otolaryngology

Credits: 1.00 CME / CNE / CPE
Advancing Treatment Options in the Management of Head and Neck Cancers
Mark Klein, MD
Rush University Medical Center

Advancing Treatment Options in the Management of Head and Neck Cancers

Start

Activity Details

Free CME/CNE/CPE
1.0 AMA PRA Category 1 Credit(s)
1.0 Contact Hour(s)
Released: October 8, 2019
Expires: October 7, 2020
1 hour to complete

Accredited By

Rush University Medical Center

Co-Provided By

Target Audience

This activity is designed to meet the educational needs of hematologists, hematologists/oncologists, community oncologists, oncology nurses and NPs, pharmacists and other healthcare professionals involved in the treatment of patients with Head and Neck Cancers.

Learning Objectives

After completing this program, participants should be able to:

  • Summarize current best practice approaches for the management of head & neck cancer patients in the VHA, DoD and MHS settings
  • Discuss present and future clinical trials in head & neck cancer patients
  • Assess the role of immunotherapy in head & neck cancer patients

Activity Description

This educational activity is designed to provide the hematology/oncology care team with the latest developments and critical insights into the management of Head and Neck Cancers. This education will support the healthcare professional in his/her practice setting with the essential tools to critically evaluate efficacy, safety, clinical effectiveness and application.

Statement of Educational Need

Taking into consideration the continued evolution of therapeutic modalities and management strategies for Head and Neck Cancer along with the information burden placed on busy healthcare professionals, expert guidance and interpretation of the clinical significance of emerging clinical data will benefit those caring for patients with Head and Neck Cancer, allowing for ease of assessment and incorporation into clinical practice.

Faculty

Mark Klein, MD
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN


Conflict of Interest Policy/Disclosure Statement

Mark Klein, MD has no conflict of interest with any commercial interest(s) whose products or services may be mentioned in this activity.

Accreditation Statement

In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is being presented without bias and with commercial support.

Rush University Medical Center designates this enduring activity for a maximum of one (1) AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Rush University Medical Center designates this enduring activity for a maximum of one (1) continuing nursing education credit(s).

Rush University Medical Center designates this enduring activity for a maximum of one (1) continuing education unit(s) in Pharmacy.

Instructions for Receiving Credit

In order to receive credit for participating in this program, participants must listen to the program in its entirety and then complete and submit the CE evaluation form at the conclusion of the program.

Statement of Commercial Support

Supported by an educational grant from Merck, Inc.

Disclaimer Statement/ Disclosure of Unlabeled Use

Rush University and Plexus Communications ensure balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, Rush University identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Rush University to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Rush University is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Contact Information for Questions About the Activity

info@plexuscomm.com

Activity Details

Free CME/CNE/CPE
1.0 AMA PRA Category 1 Credit(s)
1.0 Contact Hour(s)
Released: October 8, 2019
Expires: October 7, 2020
1 hour to complete

Accredited By

Rush University Medical Center

Co-Provided By

Target Audience

This activity is designed to meet the educational needs of hematologists, hematologists/oncologists, community oncologists, oncology nurses and NPs, pharmacists and other healthcare professionals involved in the treatment of patients with Head and Neck Cancers.

Learning Objectives

After completing this program, participants should be able to:

  • Summarize current best practice approaches for the management of head & neck cancer patients in the VHA, DoD and MHS settings
  • Discuss present and future clinical trials in head & neck cancer patients
  • Assess the role of immunotherapy in head & neck cancer patients

Activity Description

This educational activity is designed to provide the hematology/oncology care team with the latest developments and critical insights into the management of Head and Neck Cancers. This education will support the healthcare professional in his/her practice setting with the essential tools to critically evaluate efficacy, safety, clinical effectiveness and application.

Statement of Educational Need

Taking into consideration the continued evolution of therapeutic modalities and management strategies for Head and Neck Cancer along with the information burden placed on busy healthcare professionals, expert guidance and interpretation of the clinical significance of emerging clinical data will benefit those caring for patients with Head and Neck Cancer, allowing for ease of assessment and incorporation into clinical practice.

Faculty

Mark Klein, MD
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN


Conflict of Interest Policy/Disclosure Statement

Mark Klein, MD has no conflict of interest with any commercial interest(s) whose products or services may be mentioned in this activity.

Accreditation Statement

In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is being presented without bias and with commercial support.

Rush University Medical Center designates this enduring activity for a maximum of one (1) AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Rush University Medical Center designates this enduring activity for a maximum of one (1) continuing nursing education credit(s).

Rush University Medical Center designates this enduring activity for a maximum of one (1) continuing education unit(s) in Pharmacy.

Instructions for Receiving Credit

In order to receive credit for participating in this program, participants must listen to the program in its entirety and then complete and submit the CE evaluation form at the conclusion of the program.

Statement of Commercial Support

Supported by an educational grant from Merck, Inc.

Disclaimer Statement/ Disclosure of Unlabeled Use

Rush University and Plexus Communications ensure balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, Rush University identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Rush University to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Rush University is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Contact Information for Questions About the Activity

info@plexuscomm.com

Otolaryngology Presentations

1.00 CME / CNE / CPE
Rush University Medical Center
Advancing Treatment Options in the Management of Head and Neck Cancers

Advancing Treatment Options in the Management of Head and Neck Cancers

Start

Activity Details

Free CME/CNE/CPE
1.0 AMA PRA Category 1 Credit(s)
1.0 Contact Hour(s)
Released: October 8, 2019
Expires: October 7, 2020
1 hour to complete

Accredited By

Rush University Medical Center

Co-Provided By

Target Audience

This activity is designed to meet the educational needs of hematologists, hematologists/oncologists, community oncologists, oncology nurses and NPs, pharmacists and other healthcare professionals involved in the treatment of patients with Head and Neck Cancers.

Learning Objectives

After completing this program, participants should be able to:

  • Summarize current best practice approaches for the management of head & neck cancer patients in the VHA, DoD and MHS settings
  • Discuss present and future clinical trials in head & neck cancer patients
  • Assess the role of immunotherapy in head & neck cancer patients

Activity Description

This educational activity is designed to provide the hematology/oncology care team with the latest developments and critical insights into the management of Head and Neck Cancers. This education will support the healthcare professional in his/her practice setting with the essential tools to critically evaluate efficacy, safety, clinical effectiveness and application.

Statement of Educational Need

Taking into consideration the continued evolution of therapeutic modalities and management strategies for Head and Neck Cancer along with the information burden placed on busy healthcare professionals, expert guidance and interpretation of the clinical significance of emerging clinical data will benefit those caring for patients with Head and Neck Cancer, allowing for ease of assessment and incorporation into clinical practice.

Faculty

Mark Klein, MD
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN


Conflict of Interest Policy/Disclosure Statement

Mark Klein, MD has no conflict of interest with any commercial interest(s) whose products or services may be mentioned in this activity.

Accreditation Statement

In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is being presented without bias and with commercial support.

Rush University Medical Center designates this enduring activity for a maximum of one (1) AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Rush University Medical Center designates this enduring activity for a maximum of one (1) continuing nursing education credit(s).

Rush University Medical Center designates this enduring activity for a maximum of one (1) continuing education unit(s) in Pharmacy.

Instructions for Receiving Credit

In order to receive credit for participating in this program, participants must listen to the program in its entirety and then complete and submit the CE evaluation form at the conclusion of the program.

Statement of Commercial Support

Supported by an educational grant from Merck, Inc.

Disclaimer Statement/ Disclosure of Unlabeled Use

Rush University and Plexus Communications ensure balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, Rush University identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Rush University to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Rush University is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Contact Information for Questions About the Activity

info@plexuscomm.com

Activity Details

Free CME/CNE/CPE
1.0 AMA PRA Category 1 Credit(s)
1.0 Contact Hour(s)
Released: October 8, 2019
Expires: October 7, 2020
1 hour to complete

Accredited By

Rush University Medical Center

Co-Provided By

Target Audience

This activity is designed to meet the educational needs of hematologists, hematologists/oncologists, community oncologists, oncology nurses and NPs, pharmacists and other healthcare professionals involved in the treatment of patients with Head and Neck Cancers.

Learning Objectives

After completing this program, participants should be able to:

  • Summarize current best practice approaches for the management of head & neck cancer patients in the VHA, DoD and MHS settings
  • Discuss present and future clinical trials in head & neck cancer patients
  • Assess the role of immunotherapy in head & neck cancer patients

Activity Description

This educational activity is designed to provide the hematology/oncology care team with the latest developments and critical insights into the management of Head and Neck Cancers. This education will support the healthcare professional in his/her practice setting with the essential tools to critically evaluate efficacy, safety, clinical effectiveness and application.

Statement of Educational Need

Taking into consideration the continued evolution of therapeutic modalities and management strategies for Head and Neck Cancer along with the information burden placed on busy healthcare professionals, expert guidance and interpretation of the clinical significance of emerging clinical data will benefit those caring for patients with Head and Neck Cancer, allowing for ease of assessment and incorporation into clinical practice.

Faculty

Mark Klein, MD
Assistant Professor of Medicine
University of Minnesota
Minneapolis, MN


Conflict of Interest Policy/Disclosure Statement

Mark Klein, MD has no conflict of interest with any commercial interest(s) whose products or services may be mentioned in this activity.

Accreditation Statement

In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is being presented without bias and with commercial support.

Rush University Medical Center designates this enduring activity for a maximum of one (1) AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Rush University Medical Center designates this enduring activity for a maximum of one (1) continuing nursing education credit(s).

Rush University Medical Center designates this enduring activity for a maximum of one (1) continuing education unit(s) in Pharmacy.

Instructions for Receiving Credit

In order to receive credit for participating in this program, participants must listen to the program in its entirety and then complete and submit the CE evaluation form at the conclusion of the program.

Statement of Commercial Support

Supported by an educational grant from Merck, Inc.

Disclaimer Statement/ Disclosure of Unlabeled Use

Rush University and Plexus Communications ensure balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, Rush University identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Rush University to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Rush University is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.

Contact Information for Questions About the Activity

info@plexuscomm.com